Shanghai Stock Exchange Composite Index & Eli Lilly and Company
5 shared events · Importance 4 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Shanghai Stock Exchange Composite Index: The Shanghai Composite index added modest gains, but later shed points, indicating a mixed performance compared to other Asian markets.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
May 20, 2026 · 72 articles
Business
Shanghai Stock Exchange Composite Index: Fell up to 3.1%, but less exposed to AI boom.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Apr 20, 2026 · 344 articles
International
Shanghai Stock Exchange Composite Index: The Shanghai Stock Exchange Composite Index index fell, indicating a mixed performance in Asian markets despite the general optimism surrounding the U.S.-Iran ceasefire.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 18, 2026 · 309 articles
International
Shanghai Stock Exchange Composite Index: The Shanghai Stock Exchange Composite Index index fell, indicating a mixed performance in Asian markets despite the general optimism surrounding the U.S.-Iran ceasefire.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 27, 2026 · 101 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Shanghai Stock Exchange Composite Index and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard